Risk-informed Shared-decision Making Engagement Strategy for Patients With Prediabetes

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-75
SponsorJohns Hopkins University

About this trial

The goal of this clinical trial is to learn if knowing risk for diabetes can help adult patients with prediabetes take steps to get care and prevent diabetes. The main questions it aims to answer are:

* Does a shared-decision making visit with a health care team member to talk about the participant's diabetes risk increase participants' taking steps to prevent diabetes? * Does a simple message in the patient portal about the participant's diabetes risk increase participants' taking steps to prevent diabetes?

Researchers will compare the visit with usual care at the clinic to see if the visit increases participants' taking steps to prevent diabetes. Separately, the researchers will compare the patient message with usual care at the clinic to see if the message increases participants' taking steps to prevent diabetes.

Participants will:

* Complete surveys at the beginning of the study and up to 2 additional surveys * If the participant falls into the shared decision-making group, the participant will have one 30-minute visit with a healthcare team member to talk about risk of diabetes and how to lower it.

Eligibility criteria

Qualifiers

prediabetes based on most recent HbA1c (5.7-6.4%) or fasting plasma glucose (100-125 mg/dL) in prior 12 months

active patient portal account (MyChart)

patient receiving primary care at Johns Hopkins Community Physicians in Frederick

have overweight or obesity (BMI ≥ 25 kg/m2)

Disqualifiers

have diabetes (HbA1c > 6.4% in prior 6 months or on diabetes registry)

have dementia

previously participated in the Diabetes Prevention Program (DPP)

Trial design

Treatments tested in this trial

  • Risk Informed Shared Decision-Making Strategy (RISE)
  • Low Touch Messaging Strategy (LTM)

Treatment groups

120 Participants
are divided into 3 treatment groups

Sponsors and collaborators

Johns Hopkins University

Lead sponsor

American Diabetes Association

Collaborator